Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-α2b and folinic acid. The “GISCAD” experience
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (11) , 1611-1616
- https://doi.org/10.1016/0959-8049(94)00190-g
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.Journal of Clinical Oncology, 1992
- Double biochemical modulation of 5-fluorouracil by leucovorin and cyclic low dose interferon alpha 2b in advanced colorectal cancer patientsAnnals of Oncology, 1992
- Phase II study of 5-fluorouracil plus leucovorin and interferon alpha 2b in advanced colorectal cancerEuropean Journal Of Cancer, 1992
- Folinic acid + 5-Fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of ‘GISCAD’ (Italian Group for the Study of Digestive Tract Cancer)Annals of Oncology, 1991
- Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma assessment of activity and toxicityCancer, 1990
- Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma.Journal of Clinical Oncology, 1990
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989
- Reporting results of cancer treatmentCancer, 1981
- Inhibition by Interferon of Thymidine Uptake in Chemostat Cultures of L1210 CellsIntervirology, 1978
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958